Sanofi-Aventis SA has offered to buy U.S. biotechnology company Genzyme Corp. for $18.5 billion, or $69 per share, the French drug maker said Sunday.
Read the original post by MarketWatch
Consumer Electronics in the News
Sanofi-Aventis SA has offered to buy U.S. biotechnology company Genzyme Corp. for $18.5 billion, or $69 per share, the French drug maker said Sunday.
Read the original post by MarketWatch